Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Adjunctive Zonisamide for Bipolar Disorder

NCT00047567 is registered in ClinicalTrials.gov with Elan Pharmaceuticals as lead sponsor.

NCT NCT00047567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00047567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Adjunctive Zonisamide for Bipolar Disorder
Lead sponsor
Elan Pharmaceuticals
Phase
Phase 4
Overall status
Terminated
Start date
July 31, 2002
Completion date
July 31, 2002
Enrollment
20
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorders